Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

Todd Neale

August 12, 2024

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Todd Neale

June 27, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

Advertisement

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Scientific Statement Reviews Current Antithrombotic Options in PAD

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Top Endovascular News of 2023

AHA Selects 2023’s Leading Cardiovascular Research

Statin Therapy Still Lacking for Many US Patients With ASCVD

AHA Scientific Statement Addresses Health Disparities in PAD

Only Half of Revascularized PAD Patients Receive GDMT

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content